University of Texas MD Anderson Cancer Center, Texas
Daniel Arellano, PhD, ACNP-BC, FNP-BC, AOCNP, FCCM, FAANP
Assistant Professor, Cizik School of Nursing at UTHealth Houston
Acute Care Nurse Practitioner, MD Anderson Cancer Center
Dr. Daniel Arellano is an Acute Care Nurse Practitioner in the Intensive Care Unit at MD Anderson Cancer Center and an Assistant Professor of Nursing at the University of Texas Health Science Center at Houston (UTHealth). With over 13 years of academic experience, he teaches undergraduate pathophysiology, high acuity nursing, and acute care nurse practitioner curriculum, blending clinical expertise with educational innovation.
He began his healthcare career as an EMT and paramedic before becoming a registered nurse and advanced practice provider. This progression through multiple levels of clinical practice provides him with a comprehensive perspective on critical care delivery from prehospital to tertiary settings.
Dr. Arellano earned his undergraduate and graduate nursing degrees from the University of Rochester and completed his PhD at UTHealth, where his dissertation examined vasopressor titration strategies in septic shock. His scholarship and clinical leadership have directly influenced national practice standards. He co-authored a pivotal study in the American Journal of Critical Care that informed The Joint Commission’s titration standards for vasoactive medications.
A Fellow of both the American College of Critical Care Medicine and the American Association of Nurse Practitioners, Dr. Arellano is also a recipient of SCCM’s Norma J. Shoemaker Award for Critical Care Nursing Excellence, one of the organization’s highest honors.
He has served in multiple SCCM leadership roles, including Nursing Section Chair and committee appointments focused on education, diversity, and pharmacotherapy. As a national and international speaker, Dr. Arellano continues to advance evidence-based critical care through teaching, scholarship, and professional service.
Response to Immune Checkpoint Inhibitors in Cancer and Their Effects on Monocytes in Septic Shock
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure information not submitted.
